content

New Study Findings Show Mixture of DuPont Probiotic Strains and Lactoferrin Reduces Common Cause of Vaginal Discomfort

New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing...

Indiaโ€™s growing biopharma market: monoclonal antibodies R&D and production Designing sterile connection systems

Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability. ...

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities...

OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of...

DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers

DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at...
00:02:39

KNect365 Life Sciences ePharma 2017

KNect365 Life Sciences' ePharma 2017, held March 6-8, 2017 in New York City, brought together thought leaders, industry trailblazers, and technology partners within the...

Quotient Sciences Conducts Integrated Translational Pharmaceutics Program in U.S. With Druggability Technologies

Quotient Sciences, a leading drug development services organization, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration to utilize Quotientโ€™s integrated Translational...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read